1 | therapy | 127,923 |
2 | theraphy | 11 |
3 | otoscope | 6 |
4 | dose/potency | 4 |
5 | pgb-acet | 3 |
6 | 2,4-diamino-6-hydroxypyrimidine | 2 |
7 | 5-fluoropyrimidine | 2 |
8 | hydralazine/nitrate | 2 |
9 | impregnations | 2 |
10 | mab+methotrexate | 2 |
11 | musli | 2 |
12 | oxfendazole/praziquantel | 2 |
13 | ras-inhibition | 2 |
14 | test-battery | 2 |
15 | therapy/treatment | 2 |
16 | therapy® | 2 |
17 | treatment.patients | 2 |
18 | *tamoxifen | 1 |
19 | aliskiren/hydrochlorthiazide | 1 |
20 | alpha-pharmaceutical | 1 |
21 | am+lf | 1 |
22 | aspirin-extended-release | 1 |
23 | bevacizumab-taxanes | 1 |
24 | cefepime/amikacin | 1 |
25 | clonazepam-deanxit | 1 |
26 | coloproctopathy | 1 |
27 | cyanurate | 1 |
28 | docetaxel+vandetanib | 1 |
29 | egfr-tkis-chemotherapy | 1 |
30 | eribulin/trastuzumab | 1 |
31 | estrogen/levonorgestrel | 1 |
32 | etanercept+methotrexate | 1 |
33 | ezg/rtg | 1 |
34 | formoterol/fluticasone | 1 |
35 | fs/fit | 1 |
36 | gents | 1 |
37 | haloperidol-beclamide | 1 |
38 | hcscs/hmscs | 1 |
39 | ifn+ga | 1 |
40 | il-17a/ifn-γ | 1 |
41 | interventions.based | 1 |
42 | lovastatin/cyclosporin | 1 |
43 | lymphdiaral | 1 |
44 | macronutrient/s | 1 |
45 | modifiers/protectors | 1 |
46 | mra/asi | 1 |
47 | nanovehicle | 1 |
48 | o3fa-cytidine | 1 |
49 | oftelmisartan/hydrochlorothiazide | 1 |
50 | orphenadrine/paracetamol | 1 |
51 | post-dxa | 1 |
52 | potency/dose | 1 |
53 | product-fibrin | 1 |
54 | protection/infrastructure | 1 |
55 | r-pro-urokinase | 1 |
56 | regimen-rapid | 1 |
57 | rifampicin-trimethoprim | 1 |
58 | smoking/hypercholesterolemia | 1 |
59 | t180⇒i | 1 |
60 | therapy+o | 1 |
61 | therapy-alone | 1 |
62 | therapy-matched | 1 |
63 | therapy-treatment | 1 |
64 | therapy.compared | 1 |
65 | therapy/yoga | 1 |
66 | therpy | 1 |
67 | therqpy | 1 |
68 | totocillin | 1 |
69 | tr/avg | 1 |
70 | treatments.-musiani | 1 |
71 | treatments.although | 1 |
72 | treatments/procedures | 1 |
73 | vaccines/chemicals | 1 |
74 | vollenweideri | 1 |
75 | weight-loss-treatment | 1 |
1 | *tamoxifen | 1 |
2 | 2,4-diamino-6-hydroxypyrimidine | 2 |
3 | 5-fluoropyrimidine | 2 |
4 | aliskiren/hydrochlorthiazide | 1 |
5 | alpha-pharmaceutical | 1 |
6 | am+lf | 1 |
7 | aspirin-extended-release | 1 |
8 | bevacizumab-taxanes | 1 |
9 | cefepime/amikacin | 1 |
10 | clonazepam-deanxit | 1 |
11 | coloproctopathy | 1 |
12 | cyanurate | 1 |
13 | docetaxel+vandetanib | 1 |
14 | dose/potency | 4 |
15 | egfr-tkis-chemotherapy | 1 |
16 | eribulin/trastuzumab | 1 |
17 | estrogen/levonorgestrel | 1 |
18 | etanercept+methotrexate | 1 |
19 | ezg/rtg | 1 |
20 | formoterol/fluticasone | 1 |
21 | fs/fit | 1 |
22 | gents | 1 |
23 | haloperidol-beclamide | 1 |
24 | hcscs/hmscs | 1 |
25 | hydralazine/nitrate | 2 |
26 | ifn+ga | 1 |
27 | il-17a/ifn-γ | 1 |
28 | impregnations | 2 |
29 | interventions.based | 1 |
30 | lovastatin/cyclosporin | 1 |
31 | lymphdiaral | 1 |
32 | mab+methotrexate | 2 |
33 | macronutrient/s | 1 |
34 | modifiers/protectors | 1 |
35 | mra/asi | 1 |
36 | musli | 2 |
37 | nanovehicle | 1 |
38 | o3fa-cytidine | 1 |
39 | oftelmisartan/hydrochlorothiazide | 1 |
40 | orphenadrine/paracetamol | 1 |
41 | otoscope | 6 |
42 | oxfendazole/praziquantel | 2 |
43 | pgb-acet | 3 |
44 | post-dxa | 1 |
45 | potency/dose | 1 |
46 | product-fibrin | 1 |
47 | protection/infrastructure | 1 |
48 | r-pro-urokinase | 1 |
49 | ras-inhibition | 2 |
50 | regimen-rapid | 1 |
51 | rifampicin-trimethoprim | 1 |
52 | smoking/hypercholesterolemia | 1 |
53 | t180⇒i | 1 |
54 | test-battery | 2 |
55 | theraphy | 11 |
56 | therapy | 127,923 |
57 | therapy+o | 1 |
58 | therapy-alone | 1 |
59 | therapy-matched | 1 |
60 | therapy-treatment | 1 |
61 | therapy.compared | 1 |
62 | therapy/treatment | 2 |
63 | therapy/yoga | 1 |
64 | therapy® | 2 |
65 | therpy | 1 |
66 | therqpy | 1 |
67 | totocillin | 1 |
68 | tr/avg | 1 |
69 | treatment.patients | 2 |
70 | treatments.-musiani | 1 |
71 | treatments.although | 1 |
72 | treatments/procedures | 1 |
73 | vaccines/chemicals | 1 |
74 | vollenweideri | 1 |
75 | weight-loss-treatment | 1 |
1 | ifn+ga | 1 |
2 | therapy/yoga | 1 |
3 | smoking/hypercholesterolemia | 1 |
4 | post-dxa | 1 |
5 | eribulin/trastuzumab | 1 |
6 | docetaxel+vandetanib | 1 |
7 | therapy-matched | 1 |
8 | therapy.compared | 1 |
9 | interventions.based | 1 |
10 | regimen-rapid | 1 |
11 | haloperidol-beclamide | 1 |
12 | oftelmisartan/hydrochlorothiazide | 1 |
13 | aliskiren/hydrochlorthiazide | 1 |
14 | nanovehicle | 1 |
15 | 5-fluoropyrimidine | 2 |
16 | 2,4-diamino-6-hydroxypyrimidine | 2 |
17 | o3fa-cytidine | 1 |
18 | therapy-alone | 1 |
19 | formoterol/fluticasone | 1 |
20 | otoscope | 6 |
21 | protection/infrastructure | 1 |
22 | aspirin-extended-release | 1 |
23 | r-pro-urokinase | 1 |
24 | potency/dose | 1 |
25 | hydralazine/nitrate | 2 |
26 | cyanurate | 1 |
27 | mab+methotrexate | 2 |
28 | etanercept+methotrexate | 1 |
29 | am+lf | 1 |
30 | ezg/rtg | 1 |
31 | tr/avg | 1 |
32 | treatments.although | 1 |
33 | musli | 2 |
34 | treatments.-musiani | 1 |
35 | vollenweideri | 1 |
36 | mra/asi | 1 |
37 | t180⇒i | 1 |
38 | alpha-pharmaceutical | 1 |
39 | lymphdiaral | 1 |
40 | estrogen/levonorgestrel | 1 |
41 | oxfendazole/praziquantel | 2 |
42 | orphenadrine/paracetamol | 1 |
43 | rifampicin-trimethoprim | 1 |
44 | *tamoxifen | 1 |
45 | cefepime/amikacin | 1 |
46 | totocillin | 1 |
47 | product-fibrin | 1 |
48 | lovastatin/cyclosporin | 1 |
49 | ras-inhibition | 2 |
50 | therapy+o | 1 |
51 | macronutrient/s | 1 |
52 | hcscs/hmscs | 1 |
53 | bevacizumab-taxanes | 1 |
54 | treatments/procedures | 1 |
55 | vaccines/chemicals | 1 |
56 | impregnations | 2 |
57 | modifiers/protectors | 1 |
58 | gents | 1 |
59 | treatment.patients | 2 |
60 | pgb-acet | 3 |
61 | fs/fit | 1 |
62 | clonazepam-deanxit | 1 |
63 | weight-loss-treatment | 1 |
64 | therapy-treatment | 1 |
65 | therapy/treatment | 2 |
66 | dose/potency | 4 |
67 | theraphy | 11 |
68 | coloproctopathy | 1 |
69 | therapy | 127,923 |
70 | egfr-tkis-chemotherapy | 1 |
71 | therqpy | 1 |
72 | therpy | 1 |
73 | test-battery | 2 |
74 | therapy® | 2 |
75 | il-17a/ifn-γ | 1 |